United States · Who invested in Mnemosyne Pharmaceuticals?
Mnemosyne Pharmaceuticals's investors include Atlas Venture, Slater Technology Fund, Access BridgeGap Ventures and Clal Biotechnology.
2013
$5.4MSeries A$6.0MSeries AUnited States · Series A startup
Who invested in Mnemosyne Pharmaceuticals
2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$11Mraised across 2 rounds since 2012, from 2 sources
$5.4MSeries A$6.0MSeries A
- Latest round
- Series A, $6.0MJun 2013
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $5.4M Feb 2012
- Biggest round
- $6.0M Series A · Jun 2013
- Between rounds
- 16 months from the last two
The rounds
- Jun 2013Series A$6.0M2 new
Reported by pbn.comSEC filing: $8.4M sold, first sale Feb 2012
- Feb 2012Series A$5.4M2 new
Reported by masshightech.comSEC filing: $3.2M sold, first sale Feb 2012
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2012Series A2013
Atlas Venture
Slater Technology FundAccess BridgeGap VenturesClal Biotechnology
Atlas VentureSlater Technology FundAccess BridgeGap VenturesClal BiotechnologyEveryone who backed them
Access BridgeGap VenturesGrowth equity1round
Clal BiotechnologyVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Mnemosyne Pharmaceuticals
How much has Mnemosyne Pharmaceuticals raised?
Mnemosyne Pharmaceuticals has raised $11M across 2 rounds since 2012.
When did Mnemosyne Pharmaceuticals last raise?
Mnemosyne Pharmaceuticals's most recent round was a Series A of $6.0M in Jun 2013.
What was Mnemosyne Pharmaceuticals's biggest round?
Its most recent round, $6.0M in Jun 2013, is also its largest on record.
Who backed Mnemosyne Pharmaceuticals first?
Mnemosyne Pharmaceuticals's first round on record, in Feb 2012, was backed by Slater Technology Fund and Access BridgeGap Ventures.
What stage is Mnemosyne Pharmaceuticals at?
Mnemosyne Pharmaceuticals's latest named round is a Series A, in Jun 2013.
Where is Mnemosyne Pharmaceuticals based?
Mnemosyne Pharmaceuticals is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.